AFT expects half-year operating loss of just under $2 million

AFT expects half-year operating loss of just under $2 million
AFT listed on the NZX in 2015. Here, managing director Hartley Atkinson, accompanied by wife Maree, rings the bell at the NZX to signal the sharemarket listing. (Image: Getty)
John Anthony
New Zealand drug manufacturer AFT Pharmaceuticals expects to post an operating loss of just under $2 million when it releases its results for the six months to Sept 30 this month.A statement to the NZX on Friday cited lower international and Asian sales compared with last year’s first half.One-off factors affected performance, it said.International sales dropped because of reduced orders from several of its largest customers resizing stock levels.This did not impact in-market sales, it said. In Asia, a doctors' strike in South Ko...